-
2
-
-
0033994836
-
MRI and clinical activity in MS patients after terminating treatment with interferon beta-1b
-
Richert, ND, Zierak, MC, Bash, CN, Lewis, BK, McFarland, HF, Frank, JA. MRI and clinical activity in MS patients after terminating treatment with interferon beta-1b. Mult Scler 2000; 6:86-90.
-
(2000)
Mult Scler
, vol.6
, pp. 86-90
-
-
Richert, N.D.1
Zierak, M.C.2
Bash, C.N.3
Lewis, B.K.4
McFarland, H.F.5
Frank, J.A.6
-
3
-
-
0030054701
-
Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: Disease activity resumes after stopping treatment
-
Durelli, L, Bongioanni, MR, Ferrero, B, Ferri, R, Imperiale, D, Bradac, GB, et al. Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatment. Neurology 1996; 47: 123-129.
-
(1996)
Neurology
, vol.47
, pp. 123-129
-
-
Durelli, L.1
Bongioanni, M.R.2
Ferrero, B.3
Ferri, R.4
Imperiale, D.5
Bradac, G.B.6
-
4
-
-
0033596756
-
Interferon-alpha 2a reduces MRI disease activity in relapsing-remitting multiple sclerosis
-
Myhr, KM, Riise, T, Lilleas, FEG, Beiske, TG, Celius, EG, Edland, A, et al. Interferon-alpha 2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Neurology 1999; 52: 1049-1056.
-
(1999)
Neurology
, vol.52
, pp. 1049-1056
-
-
Myhr, K.M.1
Riise, T.2
Lilleas, F.E.G.3
Beiske, T.G.4
Celius, E.G.5
Edland, A.6
-
5
-
-
0037154192
-
Disease-modifying therapies in multiple sclerosis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines
-
Goodin, DS, Frohman, EM, Garmany, GP, Halper, J, Likosky, WH, Lublin, FD, et al. Disease-modifying therapies in multiple sclerosis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002; 58: 169-178.
-
(2002)
Neurology
, vol.58
, pp. 169-178
-
-
Goodin, D.S.1
Frohman, E.M.2
Garmany, G.P.3
Halper, J.4
Likosky, W.H.5
Lublin, F.D.6
-
6
-
-
0036191577
-
-
Freedman, MS, Blumhardt, LD, Brochet, B, Comi, G, Noseworthy, JH, Sandberg-Wolheim, M, et al. and the Paris Workshop Group. International consensus statement on the use of disease-modifying agents in multiple sclerosis. Mult Scler 2002; 8: 19-23.
-
Freedman, MS, Blumhardt, LD, Brochet, B, Comi, G, Noseworthy, JH, Sandberg-Wolheim, M, et al. and the Paris Workshop Group. International consensus statement on the use of disease-modifying agents in multiple sclerosis. Mult Scler 2002; 8: 19-23.
-
-
-
-
7
-
-
0042815704
-
Disease-modifying therapies for multiple sclerosis
-
Corboy, JR, Goodin, DS, Frohman, EM. Disease-modifying therapies for multiple sclerosis. Current Treatment Options in Neurology 2003, 5: 35-54
-
(2003)
Current Treatment Options in Neurology
, vol.5
, pp. 35-54
-
-
Corboy, J.R.1
Goodin, D.S.2
Frohman, E.M.3
-
8
-
-
3042686293
-
Effect of drugs in secondary disease progression in patients with multiple sclerosis
-
Kappos, L. Effect of drugs in secondary disease progression in patients with multiple sclerosis. Mult Scler 2004; 10: S46-S55.
-
(2004)
Mult Scler
, vol.10
-
-
Kappos, L.1
-
9
-
-
0036017494
-
Disability and treatment patterns of multiple sclerosis patients in United States: A comparison of veterans and non-veterans
-
Vollmer, TL, Hadjimichael, O, Preiningerova, J, Ni, W, Buenconsejo, J. Disability and treatment patterns of multiple sclerosis patients in United States: a comparison of veterans and non-veterans. J Rehabil Res Dev 2002; 39: 163-174.
-
(2002)
J Rehabil Res Dev
, vol.39
, pp. 163-174
-
-
Vollmer, T.L.1
Hadjimichael, O.2
Preiningerova, J.3
Ni, W.4
Buenconsejo, J.5
-
10
-
-
13844306541
-
Treatment patterns of multiple sclerosis patients: A comparison of veterans and non-veterans using the NARCOMS registry
-
Lo, A, Hadjimichael, O, Vollmer, TL. Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry. Mult Scler 2005; 11: 33-40.
-
(2005)
Mult Scler
, vol.11
, pp. 33-40
-
-
Lo, A.1
Hadjimichael, O.2
Vollmer, T.L.3
-
11
-
-
46849088263
-
Changing therapy in relapsing multiple sclerosis: Considerations and recommendations of a task force of the National Multiple Sclerosis Society
-
Accessed 13 January 2007 at
-
National Multiple Sclerosis Society. Changing therapy in relapsing multiple sclerosis: considerations and recommendations of a task force of the National Multiple Sclerosis Society. Treatment recommendations for physicians, Expert opinion paper, Medical Advisory Board, 2005. Accessed 13 January 2007 at: http://www.nationalmssociety.org/pdf/ forpros/Exp_ChangTherapy.pdf.
-
Treatment recommendations for physicians, Expert opinion paper, Medical Advisory Board, 2005
-
-
-
12
-
-
0032438047
-
Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a
-
Mohr, DC, Likosky, W, Boudewyn, A, Marietta, P, Dwyer, P, Van Der Wende, J. et al. Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a. Mult Scler 1998; 4: 487-489.
-
(1998)
Mult Scler
, vol.4
, pp. 487-489
-
-
Mohr, D.C.1
Likosky, W.2
Boudewyn, A.3
Marietta, P.4
Dwyer, P.5
Van Der Wende, J.6
-
13
-
-
20144382021
-
Factors related with treatment adherence to interferon β and glatiramer acetate therapy in multiple sclerosis
-
Rio, J, Porcel, J, Tellez, N, Sanchez-Betancourt, A, Tintore, M, Arevalo, MJ, et al. Factors related with treatment adherence to interferon β and glatiramer acetate therapy in multiple sclerosis. Mult Scler 2005; 11: 306-309.
-
(2005)
Mult Scler
, vol.11
, pp. 306-309
-
-
Rio, J.1
Porcel, J.2
Tellez, N.3
Sanchez-Betancourt, A.4
Tintore, M.5
Arevalo, M.J.6
-
14
-
-
20044388168
-
Twenty-four-month comparison of immunomodulatory treatments - a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone)
-
Haas, J, Firzlaff, M. Twenty-four-month comparison of immunomodulatory treatments - a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone). Eur J Neurol 2005; 12: 425-431.
-
(2005)
Eur J Neurol
, vol.12
, pp. 425-431
-
-
Haas, J.1
Firzlaff, M.2
-
15
-
-
0042932742
-
Interrupted therapy: Stopping and switching of the beta-interferons prescribed for MS
-
Tremlett, HL, Oger, J. Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. Neurology 2003; 61: 551-554.
-
(2003)
Neurology
, vol.61
, pp. 551-554
-
-
Tremlett, H.L.1
Oger, J.2
-
16
-
-
0030332317
-
Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: Relationship to adherence to treatment
-
Mohr, DC, Goodkin, DE, Likosky, W, Gatto, N, Neilley, LK, Griffin, C, et al. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment. Mult Scler 1966; 2: 222-226.
-
(1966)
Mult Scler
, vol.2
, pp. 222-226
-
-
Mohr, D.C.1
Goodkin, D.E.2
Likosky, W.3
Gatto, N.4
Neilley, L.K.5
Griffin, C.6
-
17
-
-
33744808980
-
on behalf of the Danish Multiple Sclerosis Study Group. Immunomodulatory treatment of multiple sclerosis in Denmark: A prospective nationwide study
-
Sorensen, PS, Koch-Henriksen, N, Ravnborg, M, Frederiksen, JL, Jensen, K, Heltberg, A, et al. on behalf of the Danish Multiple Sclerosis Study Group. Immunomodulatory treatment of multiple sclerosis in Denmark: a prospective nationwide study. Mult Scler 2006; 12: 253-264.
-
(2006)
Mult Scler
, vol.12
, pp. 253-264
-
-
Sorensen, P.S.1
Koch-Henriksen, N.2
Ravnborg, M.3
Frederiksen, J.L.4
Jensen, K.5
Heltberg, A.6
-
18
-
-
0347599145
-
Long-term interferon-beta treatment for multiple sclerosis
-
Ruggieri, RM, Settipani, N, Viviano, L, Attanasio, M, Giglia, L, Almasio, P, et al. Long-term interferon-beta treatment for multiple sclerosis. Neurol Sci 2003; 24: 361-364.
-
(2003)
Neurol Sci
, vol.24
, pp. 361-364
-
-
Ruggieri, R.M.1
Settipani, N.2
Viviano, L.3
Attanasio, M.4
Giglia, L.5
Almasio, P.6
-
19
-
-
0041372590
-
Adherence to IFNβ therapy in multiple sclerosis: An Italian clinical setting
-
Taus, C, Taffi, R, Morelli, M, Fie, A, Angeled, VA, Sgolastra, M, et al. Adherence to IFNβ therapy in multiple sclerosis: an Italian clinical setting. Mult Scler 2001; 7: S18-S128.
-
(2001)
Mult Scler
, vol.7
-
-
Taus, C.1
Taffi, R.2
Morelli, M.3
Fie, A.4
Angeled, V.A.5
Sgolastra, M.6
-
20
-
-
13844315516
-
Stopping beta-interferon therapy in multiple sclerosis: An analysis of stopping patterns
-
O'Rourke, KET, Hutchinson, M. Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns. Mult Scler 2005; 11: 46-50.
-
(2005)
Mult Scler
, vol.11
, pp. 46-50
-
-
O'Rourke, K.E.T.1
Hutchinson, M.2
-
21
-
-
0036835959
-
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta
-
Paolillo, A, Pozzillia, C, Giugnia, E, Tomassinia, V, Gasperini, C, Fiorellia, M, et al. A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta. Eur J Neurol 2002; 9: 645-655.
-
(2002)
Eur J Neurol
, vol.9
, pp. 645-655
-
-
Paolillo, A.1
Pozzillia, C.2
Giugnia, E.3
Tomassinia, V.4
Gasperini, C.5
Fiorellia, M.6
-
22
-
-
33846298073
-
Long-term emotional state of multiple sclerosis patients treated with interferon beta
-
Porcel, J, Rio, J, Sanchez-Betancourt, A, Arevalo, MJ, Tintore, M, Tellez, N, et al. Long-term emotional state of multiple sclerosis patients treated with interferon beta. Mult Scler 2006; 12: 802-807.
-
(2006)
Mult Scler
, vol.12
, pp. 802-807
-
-
Porcel, J.1
Rio, J.2
Sanchez-Betancourt, A.3
Arevalo, M.J.4
Tintore, M.5
Tellez, N.6
-
23
-
-
0348012903
-
the North Italy Multiple Sclerosis Group. A post-marketing study on interferon β 1b and 1a treatment in relapsing-remitting multiple sclerosis: Different response in drop-outs and treated patients
-
Milanese, C, La Mantia, L, Palumbo, R, Martinelli, V, Murialdo, A, Zaffaroni, M, et al. the North Italy Multiple Sclerosis Group. A post-marketing study on interferon β 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients. J Neurol Neurosurg Psychiatry 2003; 74: 1689-1692.
-
(2003)
J Neurol Neurosurg Psychiatry
, vol.74
, pp. 1689-1692
-
-
Milanese, C.1
La Mantia, L.2
Palumbo, R.3
Martinelli, V.4
Murialdo, A.5
Zaffaroni, M.6
-
24
-
-
0035468790
-
Adherence to disease-modifying therapy in multiple sclerosis: Part I
-
Holland, N, Wiesel, P, Cavallo, P, Edwards, C, Halper, J, Kalb, R, et al. Adherence to disease-modifying therapy in multiple sclerosis: Part I. Rehabil Nurs 2001; 26: 172-176.
-
(2001)
Rehabil Nurs
, vol.26
, pp. 172-176
-
-
Holland, N.1
Wiesel, P.2
Cavallo, P.3
Edwards, C.4
Halper, J.5
Kalb, R.6
-
25
-
-
0035525120
-
Adherence to disease-modifying therapy in multiple sclerosis: Part II
-
Holland, N, Wiesel, P, Cavallo, P, Edwards, C, Halper, J, Kalb, R, et al. Adherence to disease-modifying therapy in multiple sclerosis: Part II. Rehabil Nurs 2001; 26: 221-226.
-
(2001)
Rehabil Nurs
, vol.26
, pp. 221-226
-
-
Holland, N.1
Wiesel, P.2
Cavallo, P.3
Edwards, C.4
Halper, J.5
Kalb, R.6
-
26
-
-
0348223726
-
Lessons from 10 years of interferon beta-1b (Betaferon/Betaseron) treatment
-
Bayas, A, Gold, R. Lessons from 10 years of interferon beta-1b (Betaferon/Betaseron) treatment. J Neurol 2003; 250: IV3-IV8.
-
(2003)
J Neurol
, vol.250
-
-
Bayas, A.1
Gold, R.2
-
27
-
-
0033980617
-
Managing the adverse effects of interferon-β therapy in multiple sclerosis
-
Bayas, A, Rieckmann, P. Managing the adverse effects of interferon-β therapy in multiple sclerosis. Drug Safety 2000; 22: 149-159.
-
(2000)
Drug Safety
, vol.22
, pp. 149-159
-
-
Bayas, A.1
Rieckmann, P.2
-
28
-
-
0029948580
-
-
Lublin, FD, Whitaker, JN, Eidelman, BH, Miller, AE, Arnason, BG, Burks, JS. Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology 1996; 46: 12-18.
-
Lublin, FD, Whitaker, JN, Eidelman, BH, Miller, AE, Arnason, BG, Burks, JS. Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology 1996; 46: 12-18.
-
-
-
-
29
-
-
51849093444
-
Importance of adherence to and persistence with prescribed treatments in patients with multiple sclerosis
-
Munschauer, FE, Weinstock-Guttman, B. Importance of adherence to and persistence with prescribed treatments in patients with multiple sclerosis. Business briefing: U S Neurology Review 2005; 1-5.
-
(2005)
Business briefing: U S Neurology Review
, pp. 1-5
-
-
Munschauer, F.E.1
Weinstock-Guttman, B.2
-
30
-
-
10344225070
-
Strategies for managing the side effects of treatments for multiple sclerosis
-
Langer-Gould, A, Moses, HH, Murray, TJ. Strategies for managing the side effects of treatments for multiple sclerosis. Neurology 2004; 63: S35-S41.
-
(2004)
Neurology
, vol.63
-
-
Langer-Gould, A.1
Moses, H.H.2
Murray, T.J.3
-
31
-
-
22144451484
-
Factors leading patients to discontinue multiple sclerosis therapies
-
Daugherty, KK, Butler, JS, Mattingly, M, Ryan, M. Factors leading patients to discontinue multiple sclerosis therapies. J Am Pharm Assoc 2005; 45: 371-375.
-
(2005)
J Am Pharm Assoc
, vol.45
, pp. 371-375
-
-
Daugherty, K.K.1
Butler, J.S.2
Mattingly, M.3
Ryan, M.4
-
32
-
-
34047189621
-
Patient perspectives on disease-modifying therapy in multiple sclerosis
-
Johnson, KL, Kuehn, CM, Yorkston, KM, Kraft, GH, Klasner, E, Amtmann, D. Patient perspectives on disease-modifying therapy in multiple sclerosis. Int J Mult Scler Care 2006; 8: 11-18.
-
(2006)
Int J Mult Scler Care
, vol.8
, pp. 11-18
-
-
Johnson, K.L.1
Kuehn, C.M.2
Yorkston, K.M.3
Kraft, G.H.4
Klasner, E.5
Amtmann, D.6
-
33
-
-
0035018884
-
Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject
-
Mohr, DC, Boudewyn, AC, Likosky, W, Levine, E, Goodkin, DE. Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject. Ann Behav Med 2001; 23: 125-132.
-
(2001)
Ann Behav Med
, vol.23
, pp. 125-132
-
-
Mohr, D.C.1
Boudewyn, A.C.2
Likosky, W.3
Levine, E.4
Goodkin, D.E.5
-
34
-
-
0033754634
-
Multiple sclerosis, disease-modifying treatments and depression: A critical methodological review
-
Feinstein, A. Multiple sclerosis, disease-modifying treatments and depression: a critical methodological review. Mult Scler 2000; 6: 343-348.
-
(2000)
Mult Scler
, vol.6
, pp. 343-348
-
-
Feinstein, A.1
-
35
-
-
0030912908
-
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis
-
Mohr, DC, Goodkin, DE, Likosky, W, Gatto, N, Baumann, KA, Rudick, RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997; 54: 531-533.
-
(1997)
Arch Neurol
, vol.54
, pp. 531-533
-
-
Mohr, D.C.1
Goodkin, D.E.2
Likosky, W.3
Gatto, N.4
Baumann, K.A.5
Rudick, R.A.6
-
36
-
-
0032874014
-
Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis
-
Mohr, DC, Likosky, W, Dwyer, P, Van Der Wende, J, Boudewyn, AC, Goodkin, DE. Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis. Arch Neurol 1999; 56: 1263-1265.
-
(1999)
Arch Neurol
, vol.56
, pp. 1263-1265
-
-
Mohr, D.C.1
Likosky, W.2
Dwyer, P.3
Van Der Wende, J.4
Boudewyn, A.C.5
Goodkin, D.E.6
-
37
-
-
0038149171
-
Predictors of adherence to glatiramer acetate therapy in individuals with self-reported progressive forms of multiple sclerosis
-
Fraser, C, Hadjimichael, O, Vollmer, T. Predictors of adherence to glatiramer acetate therapy in individuals with self-reported progressive forms of multiple sclerosis. J Neurosci Nurs 2003; 35: 163-170.
-
(2003)
J Neurosci Nurs
, vol.35
, pp. 163-170
-
-
Fraser, C.1
Hadjimichael, O.2
Vollmer, T.3
-
38
-
-
0035486933
-
Predictors of adherence to Copaxone therapy in individuals with relapsing-remitting MS
-
Fraser, C, Hadjimichael, O, Vollmer, T. Predictors of adherence to Copaxone therapy in individuals with relapsing-remitting MS. J Neurosci Nurs 2001; 33: 231-239.
-
(2001)
J Neurosci Nurs
, vol.33
, pp. 231-239
-
-
Fraser, C.1
Hadjimichael, O.2
Vollmer, T.3
-
39
-
-
0033544299
-
Side effects of interferon beta therapy and their management
-
Walther, E, Hohlfeld, R. Side effects of interferon beta therapy and their management. Neurology 1999; 53: 1622-1627.
-
(1999)
Neurology
, vol.53
, pp. 1622-1627
-
-
Walther, E.1
Hohlfeld, R.2
-
40
-
-
0033754825
-
Interferon-beta treatment for patients with multiple sclerosis: The patients' perceptions of the side-effects
-
Gottberg, K, Gardulf, A, Fredrikson, S. Interferon-beta treatment for patients with multiple sclerosis: the patients' perceptions of the side-effects. Mult Scler 2000; 6: 349-354.
-
(2000)
Mult Scler
, vol.6
, pp. 349-354
-
-
Gottberg, K.1
Gardulf, A.2
Fredrikson, S.3
-
41
-
-
32544452724
-
Current issues in immunomodulatory treatment of multiple sclerosis. A practical approach
-
Stangel, M, Gold, R, Gass, A, Haas, J, Jung, S, Elias, W, et al. Current issues in immunomodulatory treatment of multiple sclerosis. A practical approach. J Neurol 2006; 253:I/32-I/36.
-
(2006)
J Neurol
, vol.253
-
-
Stangel, M.1
Gold, R.2
Gass, A.3
Haas, J.4
Jung, S.5
Elias, W.6
-
42
-
-
31644434217
-
The Sonya Slifka Longitudinal Multiple Sclerosis Study: Methods and sample characteristics
-
Minden, SL, Frankel, D, Hadden, L, Perloff, J, Srinath, KP, Hoaglin, DC. The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics. Mult Scler 2006; 12: 24-38.
-
(2006)
Mult Scler
, vol.12
, pp. 24-38
-
-
Minden, S.L.1
Frankel, D.2
Hadden, L.3
Perloff, J.4
Srinath, K.P.5
Hoaglin, D.C.6
-
43
-
-
0020686503
-
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
-
Poser, CM, Paty, DW, Scheinberg, L, McDonald, I, Davis, FA, Ebers, GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
-
(1983)
Ann Neurol
, vol.13
, pp. 227-231
-
-
Poser, C.M.1
Paty, D.W.2
Scheinberg, L.3
McDonald, I.4
Davis, F.A.5
Ebers, G.C.6
-
44
-
-
46849104186
-
-
Accessed 19 October 2006 at
-
US Census Bureau. Accessed 19 October 2006 at: http://www.census.gov/.
-
-
-
-
45
-
-
0003750767
-
-
home page. Accessed 29 October 2006 at
-
US Census Bureau. Current Population Survey home page. Accessed 29 October 2006 at: http://www.census.gov/cps/.
-
Current Population Survey
-
-
-
46
-
-
46849111895
-
-
MEPS, Accessed 19 October 2006 at
-
Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey (MEPS). Accessed 19 October 2006 at: http://www.meps.ahrq.gov/.
-
-
-
-
47
-
-
0003864799
-
-
Accessed 19 October 2006 at
-
National Center for Health Statistics. National Health Interview Survey. Accessed 19 October 2006 at: http://www.cdc.gov/nchs/nhis.htm.
-
National Health Interview Survey
-
-
-
48
-
-
0020841184
-
The structure of psychological distress and well-being in general populations
-
Veit, CT, Ware, JE. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol 1983; 51: 730-742
-
(1983)
J Consult Clin Psychol
, vol.51
, pp. 730-742
-
-
Veit, C.T.1
Ware, J.E.2
-
49
-
-
0028817189
-
Disease steps in multiple sclerosis: A simple approach to evaluate disease progression
-
Hohol, MJ, Orav, EJ, Weiner, HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology 1995; 45: 251-255.
-
(1995)
Neurology
, vol.45
, pp. 251-255
-
-
Hohol, M.J.1
Orav, E.J.2
Weiner, H.L.3
-
50
-
-
0029913882
-
Defining the course of multiple sclerosis: Results of an international survey
-
Lublin, FD, Reingold, SC. Defining the course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-911.
-
(1996)
Neurology
, vol.46
, pp. 907-911
-
-
Lublin, F.D.1
Reingold, S.C.2
-
51
-
-
46849119105
-
Record of physicians' activities (PPA questionnaire)
-
Chicago, IL: American Medical Association
-
Randolph, L. Record of physicians' activities (PPA questionnaire). Physician Characteristics and Distribution in the U.S. Chicago, IL: American Medical Association, 1997.
-
(1997)
Physician Characteristics and Distribution in the U.S
-
-
Randolph, L.1
-
52
-
-
46849103964
-
-
American Board of Medical Specialists. Accessed 15 December 2006 at
-
American Board of Medical Specialists. Accessed 15 December 2006 at: http://www.abms.org/.
-
-
-
-
53
-
-
46849117631
-
-
Accessed 19 October 2006 at
-
AMA DoctorFinder. Accessed 19 October 2006 at: http://webapps.ama-assn.org/doctorfinder/home.html?aps/amahg.htm.
-
-
-
-
54
-
-
46849101135
-
Getting disease-modifying drugs in the U.S
-
Northrop, D. Getting disease-modifying drugs in the U.S. Inside MS 2002; 20 (3).
-
(2002)
Inside MS
, vol.20
, Issue.3
-
-
Northrop, D.1
-
55
-
-
34249108301
-
Access to health care for people with multiple sclerosis
-
Minden, SL, Frankel, D, Hadden, L, Hoaglin, DC. Access to health care for people with multiple sclerosis. Mult Scler 2007; 13: 547-558.
-
(2007)
Mult Scler
, vol.13
, pp. 547-558
-
-
Minden, S.L.1
Frankel, D.2
Hadden, L.3
Hoaglin, D.C.4
-
56
-
-
0032576752
-
Axonal transection in the lesions of multiple sclerosis
-
Trapp, BD, Peterson, JP, Ransohoff, FM, Rudick, R, Mork, S, et al. Axonal transection in the lesions of multiple sclerosis. New Engl J Med 1998; 338: 278-285.
-
(1998)
New Engl J Med
, vol.338
, pp. 278-285
-
-
Trapp, B.D.1
Peterson, J.P.2
Ransohoff, F.M.3
Rudick, R.4
Mork, S.5
-
57
-
-
0034992601
-
Axonal and neuronal degeneration in multiple sclerosis: Mechanisms and functional consequences
-
Bjartmar, C, Trapp, BD. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 2001; 14: 271-278.
-
(2001)
Curr Opin Neurol
, vol.14
, pp. 271-278
-
-
Bjartmar, C.1
Trapp, B.D.2
-
58
-
-
9744248302
-
Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis
-
Heesen, C, Kasper, J, Segal, J, Kopke, S, Muhlhauser, I. Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis. Mult Scler 2004; 10: 643-650.
-
(2004)
Mult Scler
, vol.10
, pp. 643-650
-
-
Heesen, C.1
Kasper, J.2
Segal, J.3
Kopke, S.4
Muhlhauser, I.5
-
59
-
-
0004012988
-
Multiple sclerosis: A statistical portrait. A compendium of data on demographics, disability, and health services utilization in the United States
-
August
-
Minden, SL, Marder, WD, Harrold, LN, Dor, A. Multiple sclerosis: a statistical portrait. A compendium of data on demographics, disability, and health services utilization in the United States. Report to the National Multiple Sclerosis Society, August 1993.
-
(1993)
Report to the National Multiple Sclerosis Society
-
-
Minden, S.L.1
Marder, W.D.2
Harrold, L.N.3
Dor, A.4
|